21.42500 EUR
2.411
12.68%
Last update Dec 18, 3:33 PM CET
Main market
Day range
21.42500
22.18000
Previous close
19.014000
Open
22.18000
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
21.43
2.41
12.68%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 390.9M 152.2M 142.2M 181.2M
Cost of revenue 20.9M 11.6M 29.3M 34.8M
Gross profit 370.0M 140.5M 112.9M 146.3M
Operating expense
Research & development 58.1M 57.1M 73.7M 65.1M
Selling general and admin 121.6M 111.8M 110.3M 103.6M
Other operating expenses
Operating income 190.3M -28.4M -71.0M -22.3M
Non operating interest income
Income 3.7M 2.2M 2.3M 2.9M
Expense 9.6M 9.5M 9.4M 9.8M
Other income expense 31.5K 124.5K -140.7K -1.5M
Pretax income 184.4M -35.5M -78.3M -30.7M
Tax provision 513.2K 397.3K 290.7K 243.8K
Net income 183.9M -35.9M -78.6M -31.0M
Basic EPS -0.3 -0.7
Diluted EPS -0.3 -0.7
Basic average shares 107.4M 106.9M
Diluted average shares 107.4M 106.9M
EBITDA 194.3M -25.6M -68.5M -20.5M
Net income from continuing op. 183.9M -35.9M -78.6M -31.0M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 26 minutes

10:03
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).